The UK-based drug regulator on Friday approved a vaccine developed by Moderna, the third Kovit-19 shot to be allowed for use in the country since it was developed by Pfizer / Bioendech and Oxford / Astrogeneca, which has so far been delivered to 1.5 million people.
The Pharmaceuticals and Health Products Regulatory Agency (MHRA) claims that Moderna is the second MRNA vaccine (the Pfizer / BioNTech vaccine approved in December 2020 is an MRNA vaccine). The UK has ordered 17 million doses of the modern vaccine, which is estimated to be 94% effective.
MHRA Chief Executive June Raine said: “The provision of a third Covit-19 vaccine is a key goal to ensure that all available data is consistently evaluated in a strong and comprehensive manner, and I am proud that the company has helped make this a reality.”
“Once in use, all Covit-19 vaccines are constantly monitored by MHRA. This ensures that the benefits of protecting people against Govt-19 outweigh any side effects, ”he added.
Officials acknowledged when the UK first pre-ordered the vaccine that it would start delivering products from the spring as soon as Moderna expands its production capacity. The vaccine is available free of charge to people.
Health Secretary Matt Hancock said: “Through our vaccine distribution program we have already vaccinated nearly 1.5 million people across the UK. The modern vaccine will further enhance our vaccination program once the drugs are available from the spring. ”
The Moderna vaccine will be used by NHS and hospital staff to obtain vaccinations for maintenance staff and elderly patients; Local community services with local teams and general coaches have already registered to participate in the program; And vaccination centers across the country, ensuring that people can access a vaccine wherever they live.
An official statement said anyone with a previous history of allergic reactions to the ingredients of the Moderna vaccine should not get it, but anyone with any other allergies, such as food allergies, can get the vaccine.